Market Cap (In TWD)
621.55 Million
Revenue (In TWD)
55.85 Million
Net Income (In TWD)
-6.6 Million
Avg. Volume
59.17 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.55-27.2
- PE
- -
- EPS
- -
- Beta Value
- 0.235
- ISIN
- TW0004170006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kechang Ou
- Employee Count
- -
- Website
- https://www.vectorite.com.tw
- Ipo Date
- 2013-04-15
- Details
- Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally. It offers cell preparation product manufacturing; and collection, processing, and storage management of immune cells. The company's cell preparation products are used in the field of infectious diseases and inflammation, cancer, and tumor diseases. Vectorite Biomedical Inc. was founded in 1993 and is based in New Taipei City, Taiwan.
More Stocks
-
MHPSYMHP SE
MHPSY
-
5240ACTi Corporation
5240
-
5592
-
2758
-
2339
-
4412Science Arts, Inc.
4412
-
LCKYF
-
1375